Acute Migraine

Rimegepant Shows Efficacy and Safety in Treating Acute Migraine

Rimegepant Shows Efficacy and Safety in Treating Acute Migraine

By

Rimegepant is a safe and efficacious pharmacological treatment of acute migraine in adults.

Ubrogepant Reduces Acute Migraine Pain, Symptoms

Ubrogepant Reduces Acute Migraine Pain, Symptoms

By

Results from the ACHIEVE II study were presented at the American Headache Society's 60th Annual Scientific Meeting.

Transnasal Sphenopalatine Ganglion Block May Be Safe, Effective for Acute Migraine Treatment

Transnasal Sphenopalatine Ganglion Block May Be Safe, Effective for Acute Migraine Treatment

By

The use of transnasal sphenopalatine ganglion block is safe and effective for providing short-term relief from acute migraine headaches.

Zecuity Acute Migraine Patch No Longer Available

Zecuity Acute Migraine Patch No Longer Available

By

The FDA has posted a discontinuation notice for Zecuity, an iontophoretic transdermal system for the treatment for acute migraine in adults.

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

By

In a phase 3 trial, treatment with erenumab reduced migraine frequency, monthly migraine days, and migraine medication use in patients with episodic migraine.

Migraine Treatment During Pregnancy Linked to Adverse Events

Migraine Treatment During Pregnancy Linked to Adverse Events

By

Pregnant women who seek treatment for acute migraine may experience higher rates of preterm delivery, preeclampsia, and low birth weight compared with the general population.

Sign Up for Free e-Newsletters